"M" Protein in multiple myeloma

Ultima Vez Modificado: 21 de noviembre del 2003

Share article


Question

Dear OncoLink "Ask The Experts,"
I am currently in remission after a stem cell transplant for multiple myeloma. My M protein is 0.34. At what point would I need to start treatment again? The M protein was 6 at the time of diagnosis. I have not been on any maintenance therapy. Thank you. 

Answer

Selina M. Luger, MD, Director of the Leukemia Program and Assistant Professor of Medicine at the University of Pennsylvania, responds:

Without knowing the particulars of your case, it is difficult to comment. However, in general, it is usually the trend of the protein and not the absolute number that matters. For example, is the number going up or is it stable? Also we don't only look at the protein level but also other information, like the bones, the other blood tests and sometimes the bone marrow.


News
FDA Approves Farydak for Multiple Myeloma

Feb 25, 2015 - Farydak (panobinostat) has been approved by the U.S. Food and Drug Administration to treat multiple myeloma. Farydak inhibits the activity of histone deacetylases, which could slow the overproduction of plasma cells among people with multiple myeloma, the FDA said.



I Wish You Knew

How an oncology social worker can improve your cancer experience

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información